An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular Endocrinology

• Publication date

  2004-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ME.2004-0023PMID 15118070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.

  2003cited by this paper
• A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease

  2003cited by this paper
• Bridging structural biology and genetics by computational methods: An investigation into how the R774C mutation in the AR gene can result in complete androgen insensitivity syndrome

  2003cited by this paper
• Modulation of Estrogen Receptor α Function and Stability by Tamoxifen and a Critical Amino Acid (Asp-538) in Helix 12*

  2003cited by this paper
• Electrostatic Modulation in Steroid Receptor Recruitment of LXXLL and FXXLF Motifs

  2003cited by this paper
• The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain

  2003cited by this paper
• Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.

  2002cited by this paper
• Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.

  2002cited by this paper
• Androgen receptor (AR) coregulators: an overview.

  2002cited by this paper
• Minireview: Nuclear Receptor Coactivators-An Update.

  2002cited by this paper
• Continuum solvent molecular dynamics study of flexibility in interleukin-8.

  2001cited by this paper
• Variable expressivity and mutation databases: The androgen receptor gene mutations database

  2001cited by this paper
• Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone

  2001cited by this paper
• Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation.

  2001cited by this paper
• Participation of critical residues from the extreme C-terminal end of the human androgen receptor in the ligand binding function.

  2001cited by this paper
• Genotype versus phenotype in families with androgen insensitivity syndrome.

  2001cited by this paper
• Dynamic Coupling between the SH2 and SH3 Domains of c-Src and Hck Underlies Their Inactivation by C-Terminal Tyrosine Phosphorylation

  2001cited by this paper
• A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy.

  2001cited by this paper
• Theory and applications of the generalized born solvation model in macromolecular simulations

  2000cited by this paper
• Comparative Study of the Folding Free Energy Landscape of a Three-Stranded β-Sheet Protein with Explicit and Implicit Solvent Models

  2000cited by this paper
• Solvent mobility and the protein 'glass' transition

  2000cited by this paper
• Modification of the Generalized Born Model Suitable for Macromolecules

  2000cited by this paper
• Ligand–protein interactions in nuclear receptors of hormones

  2000cited by this paper
• How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?

  2000cited by this paper
• Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor

  2000cited by this paper
• FXXLF and WXXLF Sequences Mediate the NH2-terminal Interaction with the Ligand Binding Domain of the Androgen Receptor*

  2000cited by this paper
• Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations.

  2000cited by this paper
• Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).

  2000cited by this paper
• Nuclear-receptor ligands and ligand-binding domains.

  1999cited by this paper
• An Additional Region of Coactivator GRIP1 Required for Interaction with the Hormone-binding Domains of a Subset of Nuclear Receptors*

  1999cited by this paper
• Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions.

  1999cited by this paper
• Androgen insensitivity.

  1999cited by this paper
• Activation Function 2 in the Human Androgen Receptor Ligand Binding Domain Mediates Interdomain Communication with the NH2-terminal Domain*

  1999cited by this paper
• Multiple Signal Input and Output Domains of the 160-Kilodalton Nuclear Receptor Coactivator Proteins

  1999cited by this paper
• Update of the androgen receptor gene mutations database

  1999cited by this paper
• Steroid hormone receptors: Evolution, ligands, and molecular basis of biologic function

  1999cited by this paper
• Atomic structure of progesterone complexed with its receptor

  1998cited by this paper
• Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).

  1998cited by this paper
• Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors.

  1998cited by this paper
• A signature motif in transcriptional co-activators mediates binding to nuclear receptors

  1997cited by this paper
• The GB/SA Continuum Model for Solvation. A Fast Analytical Method for the Calculation of Approximate Born Radii

  1997cited by this paper
• Molecular basis of agonism and antagonism in the oestrogen receptor

  1997cited by this paper
• Germ-line and somatic mosaicism in the androgen insensitivity syndrome: implications for genetic counseling.

  1997cited by this paper
• Nuclear receptors spring into action

  1996cited by this paper
• Erratum: A canonical structure for the ligand-binding domain of nuclear receptors

  1996cited by this paper
• Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene

  1996cited by this paper
• A canonical structure for the ligand-binding domain of nuclear receptors

  1996cited by this paper
• The clinical and molecular spectrum of androgen insensitivity syndromes.

  1996cited by this paper
• Androgen receptor defects: historical, clinical, and molecular perspectives.

  1995cited by this paper
• Androgen receptor mutations.

  1995cited by this paper
• Androgen receptor defects : Historical, clinical, and molecular perspectives

  1995cited by this paper
• A structural role for hormone in the thyroid hormone receptor

  1995cited by this paper
• A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences.

  1994cited by this paper
• Substitution of arginine-839 by cysteine or histidine in the androgen receptor causes different receptor phenotypes in cultured cells and coordinate degrees of clinical androgen resistance.

  1994cited by this paper
• Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene.

  1992cited by this paper
• Molecular basis of androgen resistance

  1992cited by this paper
• Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome.

  1992cited by this paper
• Amber mutation creates a diagnostic MaeI site in the androgen receptor gene of a family with complete androgen insensitivity.

  1991cited by this paper
• Qualitative receptor defects in families with androgen resistance: failure of stabilization of the fibroblast cytosol androgen receptor.

  1982cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Phenotypic Features, Androgen Receptor Binding, and Mutational Analysis in 278 Clinical Cases Reported as Androgen Insensitivity Syndrome*

  year unknowncited by this paper

• Molecular rewiring and compensatory mechanisms sustain DNA recognition in mutant ZTA transcription factor: insights from molecular dynamics simulations

  2025cites this paper
• Diabetes-Associated Mutations in Proinsulin Provide a “Molecular Rheostat” of Nascent Foldability

  2022cites this paper
• Clinical, Hormonal, Genetic, and Molecular Characteristics in Androgen Insensitivity Syndrome in an Asian Indian Cohort from a Single Centre in Western India

  2021cites this paper
• In vitro Functional characterization of Androgen Receptor Gene Mutations at Arginine p.856 of the Ligand-Binding-Domain Associated with Androgen Insensitivity Syndrome.

  2021cites this paper
• Identification of Two Additional Novel Mutations in The AR gene Associated with Severe Forms of Androgen Insensitivity Syndrome.

  2019cites this paper
• Structure of the homodimeric androgen receptor ligand-binding domain

  2017cites this paper
• Whole Exome Sequencing Identifies a c.C2566T Mutation in the Androgen Receptor in a Chinese Family.

  2017cites this paper
• Physiopathologie et classification des anomalies du développement génitosexuel

  2015cites this paper
• Pathophysiology and Classification of Disorders of Sex Development

  2015cites this paper
• Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor‐axis in castration‐resistant prostate tumors

  2012cites this paper
• Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands

  2009cites this paper
• Modulation of Androgen Receptor Transcriptional Activity

  2009cites this paper
• Bicalutamide failure in prostate cancer treatment: involvement of Multi Drug Resistance proteins.

  2008cites this paper
• A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.

  2008cites this paper
• Clinical Evaluation of Leydig Cell Function

  2007cites this paper
• Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.

  2006cites this paper
• Clinical, Hormonal and Genetics Features in patients with Androgen Insensitivity Syndrome in Cytogenetic Laboratories in Semarang

  2006cites this paper
• Androgen receptor gene mutations in androgen insensitivity syndrome cause distinct patterns of reduced activation of androgen-responsive promoter constructs.

  2006cites this paper
• Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.

  2006cites this paper
• Anomalies génétiques du récepteur aux androgènes et ambiguïté sexuelle avec fonction testiculaire normale à la naissance

  2005cites this paper
• [Genetic anomalies of the androgen receptor and sexual ambiguity with normal testicular function at birth].

  2005cites this paper
• Complete Androgen Insensitivity Syndrome Caused by the R855H Mutation in the Androgen Receptor Gene

  2005cites this paper
• Molecular modelling of the androgen receptor axis: rational basis for androgen receptor intervention in androgen‐independent prostate cancer

  2005cites this paper